Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCSAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB22A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WIPI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on